The FDA has approved Seattle Genetics' breast cancer drug Tukysa (tucatinib) four months early, including in certain patients whose disease has spread to the brain. Tukysa has been approved in ...

Enter Seattle Genetics and Astellas, who are jointly developing enfortumab vedotin, an antibody-drug conjugate intended as an option for patients whose disease has progressed despite treatment with ...

Prostate cancer advancements highlight genetic mutations' impact on therapy and family health, emphasizing early treatment strategies for better outcomes. In recognition of September as Prostate ...

Groundbreaking new tests reveal patterns in our immune systems that can signal underlying disease and tell us how well we ...

Whether you're new to these technologies or looking to deepen your expertise, these tutorials offer valuable insights into building state-of-the-art language AI systems using the latest tools and ...

Welcome to the Department of Microbiology and Molecular Genetics. Each of our faculty is listed below and their contact information, as well as lab team if applicable, can be found by clicking on the ...

There are a lot of tutorials to get through early in Dying Light: The Beast. Many of them are helpful as you learn the ins and outs of the mechanics, but after a few hours, they can become an ...

Abstract: Threats that have been primarily targeting nation states and their associated entities have expanded the target zone to include the private and corporate sectors. This class of threats, well ...

During the TACCSTER 2025 poster session, Texas researchers highlight the methods, results, and insights of their work, ...

modsem is an R-package for estimating interaction (i.e., moderation) effects between latent variables in structural equation models (SEMs), based on the lavaan syntax ...

While 90% of breast cancer patients in rich countries survive five years, rates drop to as low as 40% in some low-resource nations due to late detection and delayed treatment.